Bristol-Myers Squibb | BMY - Loan Capital

Stock Price
58.26
Daily Change
0.48 0.83%
Monthly
-2.46%
Yearly
18.37%
Q2 Forecast
57.45

Bristol-Myers Squibb reported $42.85B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Abbott USD 9.9B 1.7B Dec/2025
ALKERMES USD 285.82M 639K Sep/2024
Amgen USD 50B 2.43B Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Coherus Biosciences USD 51.08M 496K Dec/2025
Drreddys Laboratories INR 129.19M 1.84M Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Gilead Sciences USD 22.13B 6M Dec/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
J&J USD 37.53B 1.91B Mar/2026
Medtronic USD 27.88B 255M Dec/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 29.59B 5.35B Dec/2025
Novo Nordisk DKK 118.94B 29.76B Dec/2025
Perrigo USD 3.6B 4.5M Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Phibro Animal Health USD 603.6M 5.92M Dec/2025
Prestige Brands USD 1.05B 39.73M Dec/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
Sanofi EUR 15.72B 150.06M Dec/2025
United Therapeutics USD 100M 100M Jun/2024
Zoetis USD 9.04B 1.97B Dec/2025